Breakthru Medicine

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

Active

Website LinkedIn

Updated: Mar 15, 2026 ·

About

Breakthru Medicine is a biotechnology company dedicated to advancing a portfolio of innovative cancer therapeutics. The company's primary focus is on addressing critical unmet clinical needs within oncology, specifically targeting aggressive solid tumors where current treatment options are limited or have been exhausted by patients.

Established in 2024 and based in Phoenix, Arizona, Breakthru Medicine specializes in developing next-generation oncology treatments. Its approach involves targeting hard-to-drug disease mechanisms to create novel therapeutic modalities designed to improve patient outcomes.

Recent News & Mentions

Jan 29, 2026FundingBreakthru Medicine - Series A

Financial History

Breakthru Medicine has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series A in January 2026.

Total Raised

$60.0M

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Jan 29, 2026	$60.0M Series A		Dave Morehead, Fred Eshelman, Mark J. Gergen

Financial History

Breakthru Medicine has raised $60.0M across 1 funding round.

Total Raised

$60.0M

Valuation

N/A

Deep Dive

Breakthru Medicine is a biotechnology company committed to the development of novel therapeutic modalities for cancer. The organization's core mission revolves around addressing significant unmet clinical needs in oncology, particularly for patients facing aggressive forms of solid tumors.

The company's strategic focus is on cancers where patients have exhausted existing treatment options, highlighting a dedication to areas of high clinical urgency. This involves a deep dive into disease mechanisms that have historically been challenging to drug, aiming to unlock new therapeutic avenues.

Breakthru Medicine is actively advancing a portfolio of innovative cancer therapeutics. These treatments are designed as next-generation oncology solutions, moving beyond conventional approaches to tackle complex biological pathways associated with tumor growth and progression.

Headquartered in Phoenix, Arizona, Breakthru Medicine was founded in 2024. The company operates with a clear vision to bring transformative treatments to patients who currently have limited prospects.

Its research and development efforts are centered on creating impactful solutions for hard-to-drug disease mechanisms. By focusing on these difficult targets, Breakthru Medicine seeks to provide new hope and improved outcomes for individuals battling aggressive solid tumors.

Sources

Frequently Asked Questions

What specific types of cancer does Breakthru Medicine prioritize in its research?

Breakthru Medicine focuses on aggressive solid tumors, particularly those with the highest unmet clinical need where patients have exhausted existing treatment options.

When and where was Breakthru Medicine established?

Breakthru Medicine was founded in 2024 and is headquartered in Phoenix, Arizona.